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Objective: The objective of this study was to determine whether asymptomatic patients at high risk for carotid stenosis
should undergo screening Duplex ultrasound (DUS), with a view to offering carotid endarterectomy (CE) to those
patients with significant stenosis.
Method: We constructed a decision analysis model to evaluate the impact of an investigate-and-operate strategy, compared
with medical management alone, on the risk of stroke in patients at high risk for carotid stenosis. We studied five
investigate-and-operate models addressing different thresholds for intervention (in terms of degree of stenosis) and the
effects of using or not using preoperative angiography.
Results: For each of the strategies, under the base case conditions (30% prevalence of >50% carotid stenosis), the number
needed to screen (NNS) and the number needed to treat (NNT) are high (213 to 769 and 13 to 144, respectively). The
strategy of angiography for >50% stenosis and CE for >70% stenosis was harmful. Other strategies were unattractive
because of unacceptably high NNT (no angiography, CE >50% stenosis), or because of unacceptably high NNS
(angiography >70%, CE >70% stenosis), or both (angiography >50% stenosis, CE >50% stenosis; no angiography, CE >
70% stenosis). At 50% prevalence of >50% stenosis, two models produced more reasonable combinations of NNT and
NNS: 11 and 370, respectively, for angiography >70%, CE >70% stenosis; and 27 and 286, respectively, for no
angiography, CE >70% stenosis. Within the range of clinically plausible values for sensitivity and specificity of DUS,
results were not greatly influenced by the measurement properties of DUS. However, angiographic or surgical rates of
stroke or death were critical to the outcomes with any strategy. Only 3% to 12% of strokes in the studied population were
prevented.
Conclusions: Screening is acceptable only in populations at >40% to 50% risk for >50% carotid stenosis, who are surgical
candidates, and who would undergo surgery if recommended. Acceptable investigate-and-operate strategies include
angiography for DUS stenosis >70%, with CE if this level of stenosis is confirmed, and CE for DUS-measured stenosis
>70% without angiographic confirmation. Surgery for asymptomatic carotid stenosis is unlikely to have a large impact
upon the burden of stroke in society. (J Vasc Surg 2002;36:541-8.)
The publication of the Asymptomatic Carotid Artery
Study (ACAS) study in 19951 was followed by a large
increase in the number of carotid endarterectomies per-
formed in the United States.2 Since then, guidelines and
position papers have recommended clinical implementa-
tion of this prophylactic surgery.3-7 As the patients dis-
cussed are, by definition, neurologically asymptomatic, it
follows that they must be identified through some form of
case-finding or screening strategy. A number of studies
have identified risk factors for carotid stenosis (age, hyper-
tension, smoking, and peripheral vascular disease)8-18 and
risk factors for stroke in patients with carotid stenosis (age,
male sex, hypertension, smoking, hyperlipidemia, diabetes,
degree of carotid stenosis, presence of ulceration, ischemic
heart disease, peripheral vascular disease, or obesity).3,19-22
Other work has focused on the prevalence of significant
carotid stenosis in different populations, from the general
population,17 to high-risk groups identified by age,18,23-26
the presence of risk factors,27,28 the presence of established
peripheral vascular disease,29 or the presence of a vascular
bruit.11-13
Once patients with significant carotid stenosis have
been identified, several different management strategies are
available. There are two main issues: whether to use angiog-
raphy to confirm the degree of stenosis, and the threshold
for surgery in view of the severity of the stenosis. Angiog-
raphy adds information in addition to DUS in 7% to 13% of
patients,30,31 but carries a risk of stroke and death.1,32-37
Because the risk of stroke in asymptomatic disease is known
to be related to the degree of stenosis,38-40 and because the
North American Symptomatic Carotid Endarterectomy
Trial (NASCET)41 and the European Carotid Stenosis
Trial (ECST)42 found a graded ability to benefit from
surgery with progressive degrees of stenosis, many surgeons
might selectively operate on patients with the most severe
stenosis. However, direct evidence for graded benefit in
asymptomatic patients is lacking in ACAS,1 which included
patients with stenosis of 60%.
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Whitty et al43 examined the interactions of these differ-
ent factors using decision analysis, considering only rela-
tively low-risk populations (1%-25% risk of carotid stenosis)
and found that screening might be harmful. To our knowl-
edge, no work has examined the risk-benefit ratio of con-
servative management (no screening, optimal medical man-
agement), compared with screening in order to offer
prophylactic carotid endarterectomy (investigate-and-op-
erate strategy) in a population at high risk: for example, in
those with peripheral vascular disease or carotid bruits. In
the absence of a series of large pragmatic randomized
controlled trials of different strategies in different popula-
tions, we felt that a decision analytic model was the best
methodology to identify the most effective diagnostic and
therapeutic approach to reduce the risk of stroke in patients
with asymptomatic carotid stenosis. To make the results
concrete and comparable, we expressed them in terms of
the number of asymptomatic patients in a particular risk
category who would need to be screened by duplex ultra-
sonography (DUS), and the number who would need to
undergo carotid endarterectomy (CE) to prevent one
stroke.
METHODS
Studies of carotid disease that provided estimates of
disease frequencies, test properties, and the risks and ben-
efits of interventions were identified through MEDLINE
searches and review of the authors’ files. Following tabula-
tion of the evidence, we determined, by consensus, a point
estimate for each variable (used in the base-case model for
each strategy), and a range of plausible values around each
point estimate for sensitivity analysis (Table I). Probability
of stroke with different degrees of stenosis was expressed as
an annualized probability, and assumed to be constant over
the time-periods examined.
We constructed decision-analytic models using Data
3.5 (Tree Age Software, Williamstown, Mass). Patient pop-
ulations considered were those at increased risk for carotid
disease, who were suitable operative candidates, and who
would be prepared to undergo surgery if offered. We
constructed a number of models that compared different
investigate-and-operate strategies with the strategy of med-
ical management without investigation for carotid stenosis.
Main outcomes were the number of patients who would
need to undergo DUS to prevent one stroke, and the
number of patients who would need to undergo CE to
prevent one stroke. For the stroke outcome, we included
stroke or death following angiography, stroke or death in
the perioperative period, and all strokes occurring during
medical management or after CE.
On the basis of strategies used in randomized con-
trolled trials and suggested in guidelines, we studied five
different approaches to the identification and management
of neurologically asymptomatic people at high risk for
carotid artery stenosis. We defined high risk as a prevalence
of 30% or greater for carotid stenosis 50%, as has been
observed in studies of patients with peripheral vascular
disease29,44 or carotid bruits.11-13,27 Three strategies in-
volved angiography in the preoperative assessment, and
two strategies did not (these latter two models eliminate
the risks of angiography, but result in some patients with
false positive DUS results undergoing CE). Degree of
stenosis is reported according to the NASCET method of
measurement45 throughout. We used the cut point of
50% and70% stenosis because they are familiar from the
NASCET results, and because much of the input data was
Table I. Values used for input variables in the base case and sensitivity analyses
Base case
value
Sensitivity analysis values
Low High
Prevalence of stenosis
Prevalence of stenosis 50%11-13,27-29,44,55-57 0.3 0.5, 0.7
Proportion of 50% stenoses that are 70%11-13,27-29,44,55-57 0.07 0.05 0.45
Test properties
Sensitivity of ultrasound for stenosis 50%46-48 0.91 0.75, 0.89 0.94
Specificity of ultrasound for stenosis 50%46-48 0.93 0.75, 0.88 0.95
Sensitivity of ultrasound for stenosis 70%48-50 0.82 0.75, 0.80 0.99
Specificity of ultrasound for stenosis 70%48-50 0.93 0.75, 0.85 0.99
Risks of investigation and intervention
Probability of angiographic stroke or death1,32-37 0.012 0.006 0.02
Probability of perioperative stroke or death1,32,64 0.018 0.001 0.06
Annual probabilities of stroke
Probability of stroke for stenosis 50%, without CE1,12,38,39,59,74-76 0.023
Probability of stroke for stenosis 50%, without CE12,38,59,75,76 0.0085
Relative risk of stroke for stenosis 70% vs stenosis 50%–69%, without
CE1,12,38,39,59,74-76
3
Probability of stroke for stenosis 50%–69%, without CE38,74,77 0.02*
Probability of stroke for stenosis 70%–99%, without CE1,39,77 0.06*
Probability of stroke after CE1,32,78 0.01 0.004 0.04
Time period for analysis1 3 5, 10
*These values are calculated from the values for relative risk of stroke for stenosis 70% vs stenosis 50%–69%, without surgery, and probability of stroke for
stenosis 50%, without surgery.
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reported in these categories. We assumed that the effective-
ness of surgery for 50% to 60% stenosis was identical with
that obtained in ACAS for60%. Strategies were defined as
follows:
● Angiography for 50% stenosis, CE for 50% stenosis.
DUS is performed on all patients. Those with DUS
50% undergo angiography, and if stenosis is confirmed
to be 50%, prophylactic CE is performed.
● Angiography for 50% stenosis, CE for 70% stenosis.
Angiography is performed if DUS stenosis is 50%, but
CE is offered only if angiographically confirmed stenosis
is 70%.
● Angiography for 70% stenosis, CE for 70% stenosis.
Angiography is performed if DUS stenosis is 70%, and
CE is offered if angiographically confirmed stenosis is
70%.
● No angiography, CE for50% stenosis. CE is offered on
the basis of DUS stenosis 50% and angiography is not
performed.
● No angiography, CE for70% stenosis. CE is offered on
the basis of DUS stenosis 70% and angiography is not
performed.
To illustrate the analysis, the decision tree for the first
strategy is shown in Fig 1.
We performed one-way sensitivity analyses for the fol-
lowing variables: sensitivity and specificity of DUS, number
of years of follow up, annual stroke rate following successful
CE, probability of perioperative stroke or death, probability
of angiographic stroke or death, and baseline probability of
carotid stenosis.
In all these analyses the following assumptions were
used. The annual stroke rate after successful CE is not
dependent on preoperative degree of stenosis and does not
change over time after surgery, within the limited time
frames examined by the model.1,45 We did not consider the
effects of competing risks on stroke outcomes over longer
periods. No discounting for future events was used. We
used sensitivity and specificity values for DUS in the iden-
tification of stenosis 50%46-48 and 70%48-50 from liter-
ature values, assumed that angiography was 100% sensitive
and 100% specific, and that the distribution of degrees of
severity observed by angiography would be similar to those
observed in DUS studies. We did not consider the effects of
prophylactic CE being performed for symptomatic carotid
stenosis in those patients who might develop hemispheric
transient ischemic attacks in the period involved, or include
in the model the effects of repeated DUS for monitoring
progression in those patients not initially offered surgery.
We modeled surgical outcomes under the assumption that
Fig 1. Decision tree for the model angiography 50% stenosis, CE 50%, comparing medical management alone
with an investigate-and-operate strategy. a, True positives; b, false positives; c, false negatives; d, true negatives; pAng,
probability of angiographic stroke or death; pHigh, proportion of 50% stenoses that are 70%; pOp, probability of
perioperative stroke or death; pStegt50, probability of stenosis 50%; pStr5069, probability of stroke for stenosis
50%-69%; pStr7099, probability of stroke for stenosis 70%-99%; pStrgt50, probability of stroke for stenosis 50%;
pStrlt50, probability of stroke for stenosis 50%; pSt_surg, probability of stroke after surgery; Sens_US, sensitivity of
ultrasound for stenosis50%; Spec_US, specificity of ultrasound for stenosis50%; years, time period for analysis; #, the
probability complementary to the probability defined at a given node.
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all patients who were advised to undergo CE underwent
surgery.
RESULTS
Results are presented for a theoretical cohort of 10,000
patients, managed by either medical management only, or
by one of the different investigate-and-operate scenarios
described previously.
Results for the base case and sensitivity analysis for the
five strategies are presented in Tables II through VI (online
only). For the strategy, angiography 50% on DUS, CE
50%, the base case predicted the prevention of 19 strokes
for the cohort as a whole for patients managed by investi-
gate-and-operate rather than medically. Under this investi-
gate-and-operate strategy, DUS was performed in the
10,000 patients (as in all the investigate-and-operate strat-
egies), and 2731 patients underwent CE. The number
needed to screen (NNS) to prevent a stroke was, therefore,
526, and the number of CEs performed to prevent each
stroke was 144. There were 386 strokes predicted in the
medically managed patients, so that the 19 strokes pre-
vented by the investigate-and-operate strategy represented
4.9% of all strokes anticipated in this cohort. One-way
sensitivity analysis, examining the effect of increasing the
prevalence of 50% stenosis in the screened population
from 30% in the base case, to 50% or 70%, resulted in lower
NNS and number needed to treat (NNT). Results were not
greatly sensitive to the measurement properties of DUS,
with the exception of very low DUS specificity (75%)
(Table II, online only). The rate of stroke or death after
angiography or after surgery affected outcomes: if the
angiographic stroke or death rate exceeded 1.8%, or if the
perioperative rate exceeded 2.5%, this strategy was harmful,
resulting in as many or more strokes as in the medically
managed comparison cohort.
The strategy of angiography if stenosis 50% followed
by CE for angiographic stenosis 70% was harmful under
all conditions for 3-year follow-up (Table III, online only).
The strategy angiography if70% stenosis followed by
CE if the stenosis was angiographically confirmed to exceed
70% resulted in the prevention of 13 strokes in the entire
cohort of 10,000 patients (3.4% of expected strokes) (Table
IV, online only). Under this strategy, if the prevalence of
50% stenosis in the population screened increased to 50%,
the NNS and NNT were 370 and 11, respectively. Higher
rates of angiographic or perioperative complications were
predicted to result in higher NNS and NNT, but the
strategy was not harmful within the range of values for these
variables examined in the sensitivity analysis.
In the strategy of performing CE without confirmatory
angiography in all patients whose DUS stenosis exceeded
50%, the NNS was 213 and the NNT was 69 (Table V,
online only). Of the cohort of 10,000 patients, 3220
underwent CE, preventing 12.2% of all strokes. Under this
strategy, results are not altered greatly by reduced DUS
sensitivity, but are markedly worse under low DUS speci-
ficity conditions. The threshold value for the perioperative
rate of stroke or death under this strategy was 3.2%; values
higher than this were associated with harm.
The final strategy examined CE for DUS stenosis
70%, without confirmatory angiography, and resulted in
prevention of 3.9% of strokes with 860 patients undergoing
CE (NNS 667, NNT 57) (Table VI, online only). Low
specificity of DUS for70% stenosis resulted in harm from
this strategy; conversely, improvement in sensitivity and
specificity of DUS towards 99% resulted in reduced NNS
and NNT. The threshold value for perioperative rate of
stroke or death under this strategy was similar to that of the
previous strategy at 3.5%.
For all strategies, increasing the time-period for the
analysis resulted in progressive reductions in the NNS and
NNT to prevent a stroke (Tables II-VI, online only; Fig 2).
An increasing prevalence of 50% stenosis in the popula-
tion examined was also associated with reductions in NNS
and NNT (Tables II, IV-VI; online only), with the excep-
tion of the strategy of angiography 50%, CE 70%,
Fig 2. Effect of prevalence of carotid stenosis30% on number needed to screen and number needed to treat, for each
of the five strategies.
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which was harmful in the base case, and under conditions of
increased prevalence became more harmful (Table III, on-
line only).
Fig 2 illustrates the effect of prevalence of50% carotid
stenosis on the NNS and NNT, for each of the five strate-
gies.
DISCUSSION
For each of the strategies, under the base-case condi-
tions, the NNS and NNT are high (213 to 769 and 13 to
144, respectively). These NNTs compare unfavorably with
the NNT of 15 CE to prevent one stroke in NASCET and
ECST51,52 in patients with symptomatic carotid stenosis of
70%. The results of two small studies suggested that in
patients with recent cerebral ischemia, significant (50%)
ipsilateral carotid stenosis was detected in 14%53 to 34%.54
On the basis of these data, the NNS to prevent one stroke
for symptomatic patients might be as low as 27.
The base case prevalence of carotid stenosis of 30% was
chosen to reflect likely results from screening elderly pop-
ulations with carotid bruits11-13,27,28,55-57, or with periph-
eral vascular disease.29,44 Routine screening in these groups
has been recommended by some investigators.27,56,58
Whitty et al43 have previously shown that screening strate-
gies were not likely to be effective and might be harmful in
populations in which the prevalence was between 1% and
25%. The overall rate of stroke for these patients with
medical management is estimated by our model at 386 per
10,000 over a 3-year period. This is in keeping with the
literature: rates of 25012, 350,59 and 42038 have been
reported. For 30% prevalence and base case conditions, one
strategy is harmful: that of angiography for 50% stenosis
and CE for70% stenosis (Table III, online only). In each
of the other models (in which the investigate-and-operate
strategy prevented stroke) the absolute number of strokes
prevented (19 to 47 strokes per 10,000 patients over 3-year
follow-up) was small in comparison with the total number
of strokes expected (386 strokes per 10,000 over 3-year
follow-up), suggesting that carotid endarterectomy for
asymptomatic disease is unlikely to have a substantial im-
pact on the burden of disease at a population level (3%-12%
of strokes in patients in these moderately high-risk catego-
ries).
In theory, offering CE to patients with moderate ste-
nosis would change the risk of each individual patient
slightly, but would have the potential to have a large impact
on the population burden of stroke (Geoffrey Rose’s pre-
ventive paradox60). However, because CE is invasive, car-
ries a small but non-negligible risk of causing stroke or
death, and is resource-intensive when compared with other
stroke-prevention strategies,61 from the standpoint of the
individual patient, it is an inherently unattractive gamble,
and from the societal point of view, the cost-effectiveness of
such a strategy would need careful scrutiny. A cost-effec-
tiveness analysis by Yin et al62 showed that under base case
conditions (which were similar to those used in our model),
the incremental cost-effectiveness of a screening strategy
for 60 year olds (with prevalence of carotid stenosis of
4.5%) was $39,495 per quality adjusted life year (QALY),
within the range generally considered to be cost-effective.
However, annual population screening from age 60 on-
wards in their models resulted in an average saving of 0.012
QALY (or 4 quality adjusted life days). We believe that this
reduction in the societal burden of disease does not justify
the implementation of a population-based screening pro-
gram with large total costs. Operating on those patients
with the highest degrees of stenosis only (eg, 70% as in
our models, or 80%), may result in larger individual
benefit, but will have even less effect on the burden of
disease as a whole (preventing 3%-4% of strokes in the
population that we studied).
Each of the strategies is unattractive because of unac-
ceptably high NNT (no angiography, CE 50% stenosis
[Table V, online only]), or because of unacceptably high
NNS (angiography 70%, CE 70% stenosis [Table IV,
online only]), or both (angiography 50% stenosis, CE
50% stenosis [Table II, online only]); no angiography,
CE 70% stenosis [Table VI, online only]. NNT for these
models was between 57 and 144, and NNS between 526
and 769. However, at 50% prevalence of 50% stenosis,
two models stand out as producing more reasonable com-
binations of NNT and NNS: 11 and 370, respectively, for
angiography 70%, CE 70% stenosis (Table IV, online
only); and 27 and 286, respectively, for no angiography,
CE 70% stenosis (Table VI, online only). We and others
have shown that clinical risk factors can be used to define
groups of patients 27,28,44 who are at particularly high risk
(40%-50%) for significant carotid stenosis. These data sug-
gest that a strategy of case finding in patients in the highest
risk groups, followed by CE for 70% stenosis (with or
without confirmatory angiography) is a reasonable ap-
proach to stroke prevention.
The other sensitivity analyses also provide further in-
sights into the clinical applicability of these strategies. Re-
sults were not greatly influenced by the measurement prop-
erties of DUS, unless the specificity was below 88% (Tables
II-V, online only), with the exception of the model “no
angiography, CE 70% stenosis.” For this model, im-
provement in the specificity of DUS resulted in marked
reductions in the NNT (from 57 to 12) and NNS (from
667 to 455) (Table VI, online only). Angiographic or
surgical rates of stroke or death were critical to the out-
comes with any strategy. In particular, in the model angiog-
raphy50%, CE50%, if the angiographic stroke or death
rate exceeded 1.8%, the overall strategy resulted in harm.
This is explained by the relatively large number of patients
who are exposed to the risks of angiography, only a small
proportion of whom are at highest risk for stroke. The
strategies angiography50%, CE50%; and no angiogra-
phy, CE 50% or 70% resulted in harm when the periop-
erative stroke or death rate exceeded 2.5%, 3.2%, or 3.5%,
respectively. In community practice, stroke-or-death rates
of 1.6% (95% confidence interval [CI], 0.7% to 3%)63 and in
RCT settings, rates of 1.2% to 2.0%1,32,64 have been re-
ported in asymptomatic patients. These estimates are close
to the threshold of causing harm, suggesting that although
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benefit is achievable outside trial settings, with these inves-
tigate-and-operate strategies, ongoing audit of achieved
results is necessary in every center that offers surgery for
asymptomatic patients.
Longer follow-up times resulted in greater benefit for
each strategy. This implies that the greatest benefit from
offering CE will be obtained by operating on those with the
greatest life expectancy and fewest competing risks for
death.
We believe that our results define conditions under
which screening for asymptomatic carotid stenosis with a
view to performing carotid endarterectomy is acceptable.
None of the strategies, even those that are associated with
fewer strokes compared with medical management, are
likely to prevent a substantial proportion of the strokes that
will be experienced by the populations in question. For this
reason, combined with the narrow range of perioperative
stroke rates associated with benefit, we feel that it is also
acceptable not to screen high risk patients if they are
neurologically asymptomatic.
Even in symptomatic patients, the cost-effectiveness of
CE from a societal standpoint has been questioned by some
analysts.65,66 In asymptomatic patients, in whom the abso-
lute benefit of surgery is smaller, and for whom the costs of
screening must also be taken into consideration, the cost-
effectiveness will be lower still.65
Furthermore, because the model assumptions included
perfect patient compliance with a recommendation for
surgery, it is worth emphasizing here that screening pa-
tients who are not operative candidates, or who would not
wish to proceed with surgery were it recommended to
them, should not be performed outside a research setting.
Inclusion of such patients in screening strategies would
further increase the NNS regardless of the model used.
From the different perspective of the vascular surgeon
who is evaluating a patient whose carotid DUS has already
been performed and has identified a stenosis 50%, our
results suggest that the strategy of angiography for 50%
stenosis, CE for 70% stenosis is harmful. We would
recommend instead either proceeding with CE on the basis
of the DUS results in patients whose DUS stenosis is70%
(particularly in centers where DUS has been validated
against angiography), or performing angiography only if
the stenosis is 70% and CE only if this degree of stenosis
is confirmed.
We used a decision-analytic approach to this problem
rather than a Markov model. Markov modeling would have
permitted an increase in the complexity of the model (for
example, incorporating stroke rates that changed over time,
the competing risk of death, or the possibility of becoming
symptomatic with transient ischemic attack or minor stroke
and being offered carotid endarterectomy for symptomatic
disease). However, because the data on which to base such
modeling were limited in the literature, we felt that such an
increase in complexity would not improve the model. Both
incorporation of death from alternative causes, and the
possibility of undergoing CE for symptoms in the medical
management arm, would have the effect of reducing any
potential benefit from an investigate-and-operate strategy.
Whether the presence of plaque ulceration or other
morphologic characteristics of plaque structure by DUS
can be used to refine the assessment of the risk-benefit ratio
of interventional strategies is unclear at present. In symp-
tomatic patients from the NASCET study with 70% to 99%
stenosis, angiographic evidence of plaque ulceration was
associated with a higher risk of stroke compared with those
without ulceration,67 and with greater benefit from sur-
gery.51 Ulceration in carotid stenosis detected with B-
mode imaging in asymptomatic patients has been reported
to be associated with an incidence of silent cerebral infarc-
tion detected by magnetic resonance imaging of 75%, com-
pared with an incidence of 25% when ulceration is absent.68
It has also been suggested that carotid plaques of different
structure have different embolic potential.69-71 However,
Hill et al72 found no correlation between the presence and
type of symptoms and plaque structure by DUS. Further
studies of these issues are needed.
Similarly, additional information regarding the optimal
management of asymptomatic patients will also be pro-
vided by the results of the Asymptomatic Carotid Surgery
Trial (ACST),73 a large study currently ongoing in Europe.
In conclusion, screening is acceptable only in popula-
tions at particularly high risk (40%-50%) for significant
carotid stenosis, who are surgical candidates and who
would undergo surgery if recommended. The strategy an-
giography for50% stenosis, CE for70% stenosis is likely
to be associated with harm. Acceptable investigate-and-
operate strategies include angiography for DUS stenosis
70%, with CE if this level of stenosis is confirmed, and CE
for DUS-measured stenosis 70% without angiographic
confirmation. Surgery for asymptomatic carotid stenosis is
not likely to have a large impact upon the burden of stroke
in society.
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Table II, online only. Expected results, base case and sensitivity analyses, for the strategy: angiography if carotid
stenosis 50%, and carotid endarterectomy if angiographic stenosis is 50%
No. of events per 10,000 patients assessed
No. of DUS
to prevent
one stroke*
No. of CEs
to prevent
one stroke*
Proportion
of strokes
prevented by
investigate-
and-operate
compared
with medical
management
(%)
Strokes in
medically
managed
patients
Strokes in
patients
managed by
investigate-
and-operate
strategy
CEs performed
in patients
managed by
investigate-
and-operate
strategy
Strokes prevented
by investigate-and-
operate rather
than medical
management
strategy*
Base case 386 367 2731 19 526 144 4.9
Prevalence of stenosis greater
than 50%
0.5 473 436 4552 37 270 123 7.8
0.7 539 505 6369 34 294 187 6.3
DUS properties for stenosis
50%
Sensitivity  0.75 386 371 2247 15 667 150 3.9
Sensitivity  0.89 386 367 2670 19 526 141 4.9
Sensitivity  0.94 386 366 2820 20 500 141 5.2
Specificity  0.75 386 382 2728 4 2500 682 1.0
Specificity  0.88 386 371 2731 15 667 182 3.9
Specificity  0.95 386 365 2729 21 476 130 5.4
Probability of angiographic
stroke or death
.006 386 347 2731 39 256 70 10.1
.02 386 393 2731 7 1429 390 †
Probability of perioperative
stroke or death
.001 386 324 2731 62 161 44 16.1
.06 386 481 2731 95 105 29 †
Probability of stroke after CE
.004 386 318 2731 68 147 40 17.6
.04 386 613 2731 227 44 12 †
Time period for analysis (y)
5 643 553 2731 90 111 30 14.0
10 1285 1019 2731 266 38 10 20.7
*Negative numbers indicate harmful strategies under these conditions.
†Harmful strategy under these conditions.








Table III, online only. Expected results, base case and sensitivity analyses, for the strategy angiography if carotid
stenosis 50%, and carotid endarterectomy if angiographic stenosis is 70%
No. of events per, 10,000 patients assessed
No. of DUS
to prevent
one stroke*
No. of CEs
to prevent
one stroke*
Proportion
of strokes
prevented by
investigate-
and-operate
compared
with medical
management
(%)
Strokes in
medically
managed
patients
Strokes in
patients managed
by investigate-
and-operate
strategy
CEs performed
in patients
managed by
investigate-
and-operate
strategy
Strokes prevented
by investigate-
and-operate
rather than
medical-
management
strategy*
Base case 386 399 191 13 769 15 †
Prevalance of stenosis 50%
0.5 473 489 319 16 625 20 †
0.7 559 579 446 20 500 22 †
DUS properties for stenosis
50%
Sensitivity  0.75 386 397 157 11 909 14 †
Sensitivity  0.89 386 398 187 12 833 16 †
Sensitivity  0.94 386 399 197 13 769 15 †
Specificity  0.75 386 414 191 28 357 7 †
Specificity  0.88 386 403 191 17 588 11 †
Specificity  0.95 386 397 191 11 909 17 †
Probability of angiographic
stroke or death
.006 386 379 191 7 1429 27 1.8
.02 386 424 191 38 263 5 †
Probability of perioperative
stroke or death
.001 386 395 191 9 1111 21 †
.06 386 407 191 21 476 9 †
Probability of stroke after CE
.004 386 395 191 9 1111 21 †
.04 386 416 191 30 333 6 †
Time period for analysis (y)
5 643 636 191 7 1429 27 1.1
10 1285 1231 191 54 185 4 4.2
*Negative numbers indicate harmful strategies under these conditions.
†Harmful strategy under these conditions.
Table IV, online only. Expected results, base case and sensitivity analyses, for the strategy angiography if carotid
stenosis 70%, and carotid endarterectomy if angiographic stenosis is 70%
No. of events per 10,000 patients assessed
No. of DUS
to prevent
one stroke*
No. of CEs
to prevent
one stroke*
Proportion
of strokes
prevented by
investigate-
and-operate
compared
with medical
management
(%)
Strokes in
medically
managed
patients
Strokes in
patients managed
by investigate-
and-operate
strategy
CEs performed
in patients
managed by
investigate-
and-operate
strategy
Strokes prevented
by investigate-
and-operate
rather than
medical-
management
strategy*
Base case 386 373 173 13 769 13 3.4
Prevalence of stenosis
50%
0.5 473 446 286 27 370 11 5.7
0.7 559 519 402 40 250 10 7.2
DUS properties for
stenosis 70%
Sensitivity  0.75 386 375 157 11 909 14 2.8
Sensitivity  0.80 386 373 167 13 769 13 3.4
Sensitivity  0.99 386 368 202 18 556 11 4.7
Specificity  0.75 386 394 173 8 1250 22 †
Specificity  0.85 386 382 172 4 2500 43 1.0
Specificity  0.99 386 366 172 20 500 9 5.2
Probability of angiographic
stroke or death
.006 386 368 173 18 556 10 4.7
.02 386 380 173 6 1667 29 1.6
Probability of perioperative
stroke or death
.001 386 370 173 16 625 11 4.1
.06 386 380 173 6 1667 29 1.6
Probability of stroke after
CE
.004 386 370 173 16 625 11 4.1
.04 386 388 173 2 5000 87 †
Time period for analysis (y)
5 643 612 173 31 323 6 4.8
10 1285 1211 173 74 135 2 5.8
*Negative numbers indicate harmful strategies under these conditions.
†Harmful strategy under these conditions.
Table V, online only. Expected results, base case and sensitivity analyses, for the strategy: no angiography, and carotid
endarterectomy if DUS stenosis is 50%
No. of events per 10,000 patients assessed
No. of DUS
to prevent
one stroke*
No. of CEs
to prevent
one stroke*
Proportion
of strokes
prevented by
investigate-
and-operate
compared
with medical
management
(%)
Strokes in
medically
managed
patients
Strokes in
patients managed
by investigate-
and-operate
strategy
CEs performed
in patients
managed by
investigate-
and-operate
strategy
Strokes prevented
by investigate-
and-operate
rather than
medical-
management
strategy*
Base case 386 339 3220 47 213 69 12.2
Prevalence of stenosis
50%
0.5 473 385 4900 88 114 56 18.6
0.7 559 430 6580 129 78 51 23.1
DUS properties for
stenosis 50%
Sensitivity  0.75 386 349 2740 37 270 74 9.6
Sensitivity  0.89 386 340 3160 46 217 69 11.9
Sensitivity  0.94 386 337 3310 49 204 68 12.7
Specificity  0.75 386 368 4480 18 556 249 4.7
Specificity  0.88 386 347 3570 39 256 92 10.1
Specificity  0.95 386 336 3080 50 200 62 13.0
Probability of perioperative
stroke or death
.001 386 284 3220 102 98 32 26.4
.06 386 474 3220 88 114 37 †
Probability of stroke after
CE
.004 386 281 3220 105 95 31 27.2
.04 386 629 3220 243 41 13 †
Time period for analysis (y)
5 643 527 3220 116 86 28 18.0
10 1285 995 3220 290 34 11 22.6
*Negative numbers indicate harmful strategies under these conditions.
†Harmful strategy under these conditions.

Table VI, online only. Expected results, base case and sensitivity analyses, for the strategy: no angiography, and carotid
endarterectomy if DUS stenosis is 70%
No. of events per 10,000 patients assessed
No. of DUS
to prevent
one stroke*
No. of CEs
to prevent
one stroke*
Proportion
of strokes
prevented by
investigate-
and-operate
compared
with medical
management
(%)
Strokes in
medically
managed
patients
Strokes in
patients managed
by investigate-
and-operate
strategy
CEs performed
in patients
managed by
investigate-
and-operate
strategy
Strokes prevented
by investigate-
and-operate
rather than
medical-
management
strategy*
Base case 386 371 860 15 667 57 3.9
Prevalence of stenosis
50%
0.5 473 438 960 35 286 27 7.4
0.7 559 505 1070 54 185 20 9.7
DUS properties for
stenosis 70%
Sensitivity  0.75 386 373 840 13 769 65 3.4
Sensitivity  0.80 386 372 850 14 714 61 3.6
Sensitivity  0.99 386 366 890 20 500 45 5.2
Specificity  0.75 386 393 2620 7 1429 374 †
Specificity  0.85 386 381 1640 5 2000 328 1.3
Specificity  0.99 386 364 270 22 455 12 5.7
Probability of perioperative
stroke or death
.001 386 375 860 11 909 78 2.8
.06 386 407 860 21 476 41 †
Probability of stroke after
CE
.004 386 356 860 30 333 29 7.8
.04 386 448 860 62 161 14 †
Time period for analysis (y)
5 643 608 860 35 286 25 5.4
10 1285 1201 860 84 119 10 6.5
*Negative numbers indicate harmful strategies under these conditions.
†Harmful strategy under these conditions.
